Copyright & License
Open access licensing supporting broad dissemination of CNS cancer research.
Creative Commons Open Access
JBSC publishes all articles under Creative Commons licensing, ensuring immediate free access while protecting author rights. This model maximizes research impact by removing barriers for clinicians and researchers worldwide.
CC BY 4.0: Articles are published under Creative Commons Attribution 4.0 International License. Anyone may share, copy, redistribute, and adapt the material for any purpose, including commercial use, with appropriate attribution.
Copyright Ownership
Authors retain copyright while granting JBSC publication rights. You maintain full ownership of your neuro-oncology research.
Self-Archiving
Deposit published versions in institutional repositories and personal websites without embargo.
Reuse Rights
Freely reuse published content for teaching, presentations, and derivative works.
Users must cite original authors, article title, journal name, volume/issue, and DOI when reusing content. Modifications should be noted. The license does not imply endorsement of derivative works.
When including previously published figures, tables, or substantial quotations, authors must obtain permissions and provide appropriate attribution.
By submitting manuscripts, authors warrant that work is original, not published elsewhere, and does not infringe third-party rights. Authors confirm necessary permissions for reproduced content.
JBSC commits to maintaining published content accessibility and integrity. We address concerns about published work following COPE guidelines.
CC BY licensing permits educational reuse of published CNS cancer research. Instructors may incorporate articles, figures, and data into educational materials with proper attribution.
Published articles may be translated with appropriate attribution. Translations must identify original source clearly for readers.
Authors who posted preprint versions before journal submission retain those preprint rights. The final published version carries CC BY license. Authors should update preprints with links to published version.
Supplementary data published with articles follows the same CC BY licensing. This enables reuse and reanalysis of CNS cancer datasets while maintaining attribution to original authors.
Open access publication does not affect patent rights. Authors with pending patents should consult technology transfer offices regarding publication timing and disclosure requirements.
Researchers may create derivative works under CC BY terms including meta-analyses, systematic reviews, and database compilations incorporating published CNS tumor data with appropriate citation.
Authors may deposit final published versions in institutional repositories immediately upon publication. Green open access deposits are permitted without embargo under CC BY license terms, enhancing institutional research profiles.
CC BY licensing permits commercial reuse with proper attribution. This includes inclusion in commercial databases, educational materials, and derivative products advancing CNS cancer knowledge.
Article metadata is shared freely with indexing services and databases facilitating discovery and citation tracking.
Publish Open Access
Maximize impact of your neuro-oncology research with open licensing.
Submit Manuscript
